Penumbra Inc (PEN)
NYSE · Healthcare · Medical Devices
Penumbra Inc is a Healthcare company with a market capitalization of $12.45B and a trailing P/E ratio of 73.0.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 6, 2026 | $0.82 | $1.08 | -24.1% |
| Q4 2025 | February 25, 2026 | $1.18 | $1.10 | +7.3% |
| Q3 2025 | November 5, 2025 | $0.97 | $0.92 | +5.4% |
| Q2 2025 | July 29, 2025 | $0.86 | $0.82 | +4.9% |
| Q1 2025 | April 23, 2025 | $0.83 | $0.67 | +23.9% |
| Q4 2024 | February 18, 2025 | $0.97 | $0.89 | +8.5% |
Other Medical Devices Stocks
Frequently Asked Questions
What is Penumbra Inc's market cap?
As of June 29, 2026, Penumbra Inc (PEN) has a market capitalization of $12.45B.
What is Penumbra Inc's P/E ratio?
Penumbra Inc trades at a trailing price-to-earnings (P/E) ratio of 73.0. Its forward P/E is 62.9.
Does Penumbra Inc pay a dividend?
Penumbra Inc does not currently pay a dividend.
What sector is PEN in?
Penumbra Inc is in the Healthcare sector, specifically the Medical Devices industry.
What was Penumbra Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), Penumbra Inc reported revenue of $1.40B and net income of $177.69M.
Ask your own questions about PEN
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.